Clinical trial
A Randomized Controlled Non-Inferiority Trial Comparing Neoplasia Detection During Colonoscopy Screening With and Without Non-Targeted Biopsies in Adult Colonic Inflammatory Bowel Disease
NCT05809999 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Non-Inferiority Trial Comparing Neoplasia Detection During Colonoscopy Screening With and Without Non-Targeted Biopsies in Adult Colonic Inflammatory Bowel Disease
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 23, 2022
- Completion date
- February 28, 2026
- Enrollment
- 1,411 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
colonic neoplasms, dysplasia, inflammatory bowel diseases